Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Javier Lopéz-Jimenéz
Observed names:
Javier López-Jiménez,
Javier López‐Jiménez,
López-Jiménez, Javier
Institutions:
Instituto Ramón y Cajal de Investigación Sanitaria,
Hospital Universitario Ramón y Cajal,
University of Córdoba
Observed institutions:
Instituto Ramón y Cajal de Investigación Sanitaria,
Hospital Universitario Ramón y Cajal,
University of Córdoba
ORCID:
0000-0002-2969-3002
Observed ORCIDs:
0000-0002-2969-3002,
0009-0001-1131-5740
OpenAlex ID:
A5079217712
Apheresis CD8+CCR7+CD45RA− T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome
2026
·
Iván García de la Torre
, Carlota García-Hoz
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Integrated Microbial Profiling Identifies Bacterial and Fungal Communities in Pseudomyxoma Peritonei Mucin
2026
·
Rafaela Pezzopane
, Marina Barbudo‐Lunar
, et al.
·
Microbial Biotechnology
PDF
Additional data: Multi-kingdom microbial communities in pseudomyxoma peritonei mucin
2026
·
Pezzopane, Rafaela
, Barbudo-Lunar, Marina
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
IBCL-271 Primary Efficacy and Safety Analysis of a Global Phase II Study of Zandelisib Administered by Intermittent Dosing (ID) in Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL): The TIDAL Study
2022
·
Tycel Phillips
, Wojciech Jurczak
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Poster: IBCL-271 Primary Efficacy and Safety Analysis of a Global Phase II Study of Zandelisib Administered by Intermittent Dosing (ID) in Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL): The TIDAL Study
2022
·
Tycel Phillips
, Wojciech Jurczak
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type